VFA
BIO icon

Virtus Fund Advisers’s Bio-Rad Laboratories Class A BIO Stock Holding History

Virtus Fund Advisers’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-69
Closed -$10K – 552
2015
Q4 		$10K Hold
69
– – ﹤0.01% 631
2015
Q3 		$9K Hold
69
– – ﹤0.01% 642
2015
Q2 		$10K Sell
69
-343
-83% -$49.1K ﹤0.01% 657
2015
Q1 		$56K Sell
412
-40
-9% -$4.96K ﹤0.01% 700
2014
Q4 		$54K Hold
452
– – ﹤0.01% 757
2014
Q3 		$51K Sell
452
-2,091
-82% -$248K ﹤0.01% 799
2014
Q2 		$304K Buy
+2,543
New +$311K ﹤0.01% 840

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Virtus Fund Advisers's BIO Position: Q1 2016 in Review

Virtus Fund Advisers sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2016, closing a stake of 69 shares — an estimated $10K sold.

Virtus Fund Advisers first reported a position in BIO in Q2 2014 and held it in 7 quarters. The position peaked at $304K in Q2 2014. 232 funds tracked by Wall St. Rank hold BIO as of Q1 2016.

  • Virtus Fund Advisers reported no remaining Bio-Rad Laboratories Class A position as of Q1 2016 after selling out during the quarter.
  • Virtus Fund Advisers sold 69 Bio-Rad Laboratories Class A shares in Q1 2016, an estimated $10K.
  • Virtus Fund Advisers first reported a position in Bio-Rad Laboratories Class A in Q2 2014 and held it in 7 quarters.
  • Virtus Fund Advisers's Bio-Rad Laboratories Class A position peaked at $304K in Q2 2014.
  • 232 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2016.

Based on Virtus Fund Advisers's 13F filing for Q1 2016, filed 11 May 2016.